LTR-Memvaxraleucel™
Take control of your cancer treatment with LTR-Memvaxraleucel™, a personalized cancer vaccine that works with your immune system to find and destroy cancer cells. Tailored specifically to your tumor profile, this innovative therapy helps your immune system mount a strong, lasting defense, lowering the risk of cancer coming back and boosting your body’s natural ability to fight the disease.
LTR-Memvaxraleucel™
A Revolutionary Cancer Vaccine
LTR-Memvaxraleucel™ represents a groundbreaking advancement in personalized cancer treatment, designed to reprogram the immune system to recognize and attack cancer cells with the same efficiency it uses to fight viral infections. This unique vaccine technology is centered around the use of dendritic cells, powerful immune cells that play a pivotal role in directing the immune response.
How LTR-Memvaxraleucel™ Works
The vaccine technology works by “tricking” the immune system into treating cancer as it would a viral infection through the reprogramming of powerful immune cells known as dendritic cells. This personalised cancer treatment technology focuses on how specific cancer antigens (e.g. unique tumor-specific identifiers) are processed by Dendritic Cells and communicated to T-cells.
This novel approach ultimately skews the immune system towards a powerful and targeted attack with durable memory potential not previously achievable through other vaccine approaches. The treatment is personalized (e.g. uses the patient’s own tumor protein and own tumor mRNA amplified), and like any successful vaccine, is designed to be long-lasting and dramatically reduce the risk of future relapse.
Benefits of LTR-Memvaxraleucel™
- Personalized Treatment
Each treatment is custom-made using the patient’s own tumor proteins and mRNA, ensuring a highly targeted attack against their specific cancer.
- Enhanced Immune Response
By reprogramming dendritic cells to communicate effectively with T-cells, this vaccine induces a powerful, long-lasting immune response.
- Reduced Risk of Relapse
Just like a successful viral vaccine, LTR-Memvaxraleucel™ is designed to build immune memory, offering durable protection and lowering the chances of cancer returning.
- Fewer Side Effects
Since the treatment uses the patient’s own cells, it’s autologous in nature, which generally results in fewer side effects compared to traditional cancer therapies.
